Dyadic International Inc (DYAI)

[tykundegex]

They have $45MM in cash, no debt, a low burn rate (~$7MM), platform that is significantly cheaper and more efficient than CHO-based gene expression, have proven the viability in industrial applications (IP sold to Dupont in 2015) and they have big pharma paying for on-going R&D. Huge potential.

If they manage to "humanize" it (which they expect by mid-2019), their addressable market is instantly much bigger.

I lied about waiting to take a more substantial position... I have just doubled my holdings today. Though I still struggle with determining the potential valuation of this company.. Nasdaq listing seems imminent, as does a lucrative series of deals as early as the back half of 2019, so the share price seems certain to rise.